Rubric Capital Management LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-09 4:06 pm Purchase |
2025-06-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 3,909,806 9.240% |
526,567 (+15.56%) |
Filing |
| 2025-05-14 4:04 pm Purchase |
2025-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 3,383,239 8.050% |
964,136 (+39.86%) |
Filing |
| 2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Rubric Capital Management LP | 2,419,103 5.960% |
2,419,103 (New Position) |
Filing |